Learn More
Norton Cancer Institute is at the forefront of cancer treatment research. Research is the reason more people than ever are beating cancer. As principal investigators on numerous trials, our cancer specialists have unparalleled experience with many innovative treatments once they are approved for broad use.Patients also may be eligible to take part in these experimental cancer treatments. Your oncologist can guide you to a treatment plan that is customized to you. Your physician may recommend joining a clinical trial for early access to experimental treatments.Norton Cancer Institute researchers also contribute to groundbreaking studies and other publications in peer-reviewed journals.
Patients with cancer who volunteer for research have access to innovative treatments and techniques that may not be available to those not participating in research studies. Clinical trial participants come from 20 different U.S. states, as well as two foreign countries.
There are four phases in a clinical trial, each with a different purpose. This helps researchers answer different questions. An early phase clinical trial, also known as a Phase 1 or sometimes Phase 1/2 trial, involves a small population of fewer than 100 participants, and the purpose is to evaluate how safe the drug is and what dose of the drug can be safely tolerated.
Meet Judy Hudson from Alabama. Judy travels to Louisville, Kentucky to participate in a clinical trial at Norton Research Institute. Being a researcher herself, she was aware of the benefits that come from research, but she was also looking for something better than the current treatment she was on.Learn more about research at Norton Research Institute by visiting NortonHealthcare.com/Research